Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans.

Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, Noble SM.

Cell. 2008 Oct 3;135(1):174-88. doi: 10.1016/j.cell.2008.07.046.

2.

A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans.

Chun CD, Brown JC, Madhani HD.

Cell Host Microbe. 2011 Mar 17;9(3):243-51. doi: 10.1016/j.chom.2011.02.003.

3.

Nitrogen metabolite repression of metabolism and virulence in the human fungal pathogen Cryptococcus neoformans.

Lee IR, Chow EW, Morrow CA, Djordjevic JT, Fraser JA.

Genetics. 2011 Jun;188(2):309-23. doi: 10.1534/genetics.111.128538. Epub 2011 Mar 24.

4.

Capsule growth in Cryptococcus neoformans is coordinated with cell cycle progression.

García-Rodas R, Cordero RJ, Trevijano-Contador N, Janbon G, Moyrand F, Casadevall A, Zaragoza O.

MBio. 2014 Jun 17;5(3):e00945-14. doi: 10.1128/mBio.00945-14.

5.
6.

Identification of ENA1 as a virulence gene of the human pathogenic fungus Cryptococcus neoformans through signature-tagged insertional mutagenesis.

Idnurm A, Walton FJ, Floyd A, Reedy JL, Heitman J.

Eukaryot Cell. 2009 Mar;8(3):315-26. doi: 10.1128/EC.00375-08. Epub 2009 Jan 16.

7.
8.

Cryptococcus neoformans requires the ESCRT protein Vps23 for iron acquisition from heme, for capsule formation, and for virulence.

Hu G, Caza M, Cadieux B, Chan V, Liu V, Kronstad J.

Infect Immun. 2013 Jan;81(1):292-302. doi: 10.1128/IAI.01037-12. Epub 2012 Nov 6.

9.

Computational Analysis Reveals a Key Regulator of Cryptococcal Virulence and Determinant of Host Response.

Gish SR, Maier EJ, Haynes BC, Santiago-Tirado FH, Srikanta DL, Ma CZ, Li LX, Williams M, Crouch EC, Khader SA, Brent MR, Doering TL.

MBio. 2016 Apr 19;7(2):e00313-16. doi: 10.1128/mBio.00313-16.

10.

Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Jain N, Li L, Hsueh YP, Guerrero A, Heitman J, Goldman DL, Fries BC.

Infect Immun. 2009 Jan;77(1):128-40. doi: 10.1128/IAI.01079-08. Epub 2008 Oct 27.

11.

A flucytosine-responsive Mbp1/Swi4-like protein, Mbs1, plays pleiotropic roles in antifungal drug resistance, stress response, and virulence of Cryptococcus neoformans.

Song MH, Lee JW, Kim MS, Yoon JK, White TC, Floyd A, Heitman J, Strain AK, Nielsen JN, Nielsen K, Bahn YS.

Eukaryot Cell. 2012 Jan;11(1):53-67. doi: 10.1128/EC.05236-11. Epub 2011 Nov 11.

12.

Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.

Franzot SP, Mukherjee J, Cherniak R, Chen LC, Hamdan JS, Casadevall A.

Infect Immun. 1998 Jan;66(1):89-97.

13.

Characterization of the complete uric acid degradation pathway in the fungal pathogen Cryptococcus neoformans.

Lee IR, Yang L, Sebetso G, Allen R, Doan TH, Blundell R, Lui EY, Morrow CA, Fraser JA.

PLoS One. 2013 May 7;8(5):e64292. doi: 10.1371/journal.pone.0064292. Print 2013.

14.

Cryptococcus neoformans: virulence and host defences.

Perfect JR, Wong B, Chang YC, Kwon-Chung KJ, Williamson PR.

Med Mycol. 1998;36 Suppl 1:79-86. Review.

PMID:
9988495
15.

The F-Box protein Fbp1 regulates sexual reproduction and virulence in Cryptococcus neoformans.

Liu TB, Wang Y, Stukes S, Chen Q, Casadevall A, Xue C.

Eukaryot Cell. 2011 Jun;10(6):791-802. doi: 10.1128/EC.00004-11. Epub 2011 Apr 8.

16.

Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans.

Luberto C, Martinez-Mariño B, Taraskiewicz D, Bolaños B, Chitano P, Toffaletti DL, Cox GM, Perfect JR, Hannun YA, Balish E, Del Poeta M.

J Clin Invest. 2003 Oct;112(7):1080-94.

17.

HapX positively and negatively regulates the transcriptional response to iron deprivation in Cryptococcus neoformans.

Jung WH, Saikia S, Hu G, Wang J, Fung CK, D'Souza C, White R, Kronstad JW.

PLoS Pathog. 2010 Nov 24;6(11):e1001209. doi: 10.1371/journal.ppat.1001209.

18.

Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.

Guimarães AJ, Frases S, Cordero RJ, Nimrichter L, Casadevall A, Nosanchuk JD.

Cell Microbiol. 2010 Jun;12(6):740-53. doi: 10.1111/j.1462-5822.2010.01430.x. Epub 2010 Jan 11.

19.
20.

Novel gene functions required for melanization of the human pathogen Cryptococcus neoformans.

Walton FJ, Idnurm A, Heitman J.

Mol Microbiol. 2005 Sep;57(5):1381-96.

Supplemental Content

Support Center